ASCLS eNewsBytes

• Validation of a Software Application Using Electronic Health Records for Automatic Detection of Community Onset Sepsis May 13, 2025
  A software application was developed to identify community-onset sepsis in emergency department patients using Sepsis-3 criteria, utilizing data from electronic health records TakeCare and CliniSoft.
• Teal Health Gains FDA Approval for Cervical Cancer Screening Device May 13, 2025
  FDA approves Teal Health's Teal Wand for cervical cancer screening, offering a self-collection device and telehealth service for individuals aged 25-65 at average risk.
• Rapid Genetic Test Could Help Guide Brain Cancer Surgery May 13, 2025
  Researchers developed Ultra-Rapid droplet digital polymerase chain reaction, a rapid method for measuring genetic mutations in brain tissue samples, detecting tumor cells in as few as five cells per square millimeter.
• Element Science's Wearable Defibrillator Patch Wins FDA Approval May 13, 2025
  Element Science has received FDA approval for its wearable defibrillator patch, providing a noninvasive solution for patients at risk of sudden cardiac arrest.
• Avutometinib Triplet Active in Resistant HR+/HER2- Breast Cancer May 13, 2025
  Phase 1 findings from the 2025 American Association of Clinical Research show early clinical activity and manageable safety in patients with hormone receptor-positive, HER2-negative metastatic breast cancer following disease progression on CDK4/6 inhibitors.